Global Nimodipine Sustained Release Tablets Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nimodipine Sustained Release Tablets Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Nimodipine Sustained Release Tablets by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Nimodipine Sustained Release Tablets by Country/Region, 2017, 2022 & 2028

2.2 Nimodipine Sustained Release Tablets Segment by Type

2.2.1 30mg/Piece

2.2.2 60mg/Piece

2.2.3 Others

2.3 Nimodipine Sustained Release Tablets Sales by Type

2.3.1 Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)

2.3.2 Global Nimodipine Sustained Release Tablets Revenue and Market Share by Type (2017-2022)

2.3.3 Global Nimodipine Sustained Release Tablets Sale Price by Type (2017-2022)

2.4 Nimodipine Sustained Release Tablets Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.4.3 Others

2.5 Nimodipine Sustained Release Tablets Sales by Application

2.5.1 Global Nimodipine Sustained Release Tablets Sale Market Share by Application (2017-2022)

2.5.2 Global Nimodipine Sustained Release Tablets Revenue and Market Share by Application (2017-2022)

2.5.3 Global Nimodipine Sustained Release Tablets Sale Price by Application (2017-2022)

3 Global Nimodipine Sustained Release Tablets by Company

3.1 Global Nimodipine Sustained Release Tablets Breakdown Data by Company

3.1.1 Global Nimodipine Sustained Release Tablets Annual Sales by Company (2020-2022)

3.1.2 Global Nimodipine Sustained Release Tablets Sales Market Share by Company (2020-2022)

3.2 Global Nimodipine Sustained Release Tablets Annual Revenue by Company (2020-2022)

3.2.1 Global Nimodipine Sustained Release Tablets Revenue by Company (2020-2022)

3.2.2 Global Nimodipine Sustained Release Tablets Revenue Market Share by Company (2020-2022)

3.3 Global Nimodipine Sustained Release Tablets Sale Price by Company

3.4 Key Manufacturers Nimodipine Sustained Release Tablets Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nimodipine Sustained Release Tablets Product Location Distribution

3.4.2 Players Nimodipine Sustained Release Tablets Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nimodipine Sustained Release Tablets by Geographic Region

4.1 World Historic Nimodipine Sustained Release Tablets Market Size by Geographic Region (2017-2022)

4.1.1 Global Nimodipine Sustained Release Tablets Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Nimodipine Sustained Release Tablets Annual Revenue by Geographic Region

4.2 World Historic Nimodipine Sustained Release Tablets Market Size by Country/Region (2017-2022)

4.2.1 Global Nimodipine Sustained Release Tablets Annual Sales by Country/Region (2017-2022)

4.2.2 Global Nimodipine Sustained Release Tablets Annual Revenue by Country/Region

4.3 Americas Nimodipine Sustained Release Tablets Sales Growth

4.4 APAC Nimodipine Sustained Release Tablets Sales Growth

4.5 Europe Nimodipine Sustained Release Tablets Sales Growth

4.6 Middle East & Africa Nimodipine Sustained Release Tablets Sales Growth

5 Americas

5.1 Americas Nimodipine Sustained Release Tablets Sales by Country

5.1.1 Americas Nimodipine Sustained Release Tablets Sales by Country (2017-2022)

5.1.2 Americas Nimodipine Sustained Release Tablets Revenue by Country (2017-2022)

5.2 Americas Nimodipine Sustained Release Tablets Sales by Type

5.3 Americas Nimodipine Sustained Release Tablets Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nimodipine Sustained Release Tablets Sales by Region

6.1.1 APAC Nimodipine Sustained Release Tablets Sales by Region (2017-2022)

6.1.2 APAC Nimodipine Sustained Release Tablets Revenue by Region (2017-2022)

6.2 APAC Nimodipine Sustained Release Tablets Sales by Type

6.3 APAC Nimodipine Sustained Release Tablets Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Nimodipine Sustained Release Tablets by Country

7.1.1 Europe Nimodipine Sustained Release Tablets Sales by Country (2017-2022)

7.1.2 Europe Nimodipine Sustained Release Tablets Revenue by Country (2017-2022)

7.2 Europe Nimodipine Sustained Release Tablets Sales by Type

7.3 Europe Nimodipine Sustained Release Tablets Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nimodipine Sustained Release Tablets by Country

8.1.1 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Country (2017-2022)

8.1.2 Middle East & Africa Nimodipine Sustained Release Tablets Revenue by Country (2017-2022)

8.2 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Type

8.3 Middle East & Africa Nimodipine Sustained Release Tablets Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Nimodipine Sustained Release Tablets

10.3 Manufacturing Process Analysis of Nimodipine Sustained Release Tablets

10.4 Industry Chain Structure of Nimodipine Sustained Release Tablets

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Nimodipine Sustained Release Tablets Distributors

11.3 Nimodipine Sustained Release Tablets Customer

12 World Forecast Review for Nimodipine Sustained Release Tablets by Geographic Region

12.1 Global Nimodipine Sustained Release Tablets Market Size Forecast by Region

12.1.1 Global Nimodipine Sustained Release Tablets Forecast by Region (2023-2028)

12.1.2 Global Nimodipine Sustained Release Tablets Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Nimodipine Sustained Release Tablets Forecast by Type

12.7 Global Nimodipine Sustained Release Tablets Forecast by Application

13 Key Players Analysis

13.1 Bionpharma

13.1.1 Bionpharma Company Information

13.1.2 Bionpharma Nimodipine Sustained Release Tablets Product Offered

13.1.3 Bionpharma Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bionpharma Main Business Overview

13.1.5 Bionpharma Latest Developments

13.2 Arbor Pharmaceuticals

13.2.1 Arbor Pharmaceuticals Company Information

13.2.2 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

13.2.3 Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Arbor Pharmaceuticals Main Business Overview

13.2.5 Arbor Pharmaceuticals Latest Developments

13.3 Sofgen Pharmaceuticals

13.3.1 Sofgen Pharmaceuticals Company Information

13.3.2 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

13.3.3 Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Sofgen Pharmaceuticals Main Business Overview

13.3.5 Sofgen Pharmaceuticals Latest Developments

13.4 Pharmaceutics International

13.4.1 Pharmaceutics International Company Information

13.4.2 Pharmaceutics International Nimodipine Sustained Release Tablets Product Offered

13.4.3 Pharmaceutics International Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Pharmaceutics International Main Business Overview

13.4.5 Pharmaceutics International Latest Developments

13.5 Heritage Pharmaceuticals

13.5.1 Heritage Pharmaceuticals Company Information

13.5.2 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

13.5.3 Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Heritage Pharmaceuticals Main Business Overview

13.5.5 Heritage Pharmaceuticals Latest Developments

13.6 Bayer Vital

13.6.1 Bayer Vital Company Information

13.6.2 Bayer Vital Nimodipine Sustained Release Tablets Product Offered

13.6.3 Bayer Vital Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Bayer Vital Main Business Overview

13.6.5 Bayer Vital Latest Developments

13.7 Wuhan HITECK Biopharmaceutical

13.7.1 Wuhan HITECK Biopharmaceutical Company Information

13.7.2 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Offered

13.7.3 Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Wuhan HITECK Biopharmaceutical Main Business Overview

13.7.5 Wuhan HITECK Biopharmaceutical Latest Developments

13.8 Qilu Pharmaceutical

13.8.1 Qilu Pharmaceutical Company Information

13.8.2 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

13.8.3 Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Qilu Pharmaceutical Main Business Overview

13.8.5 Qilu Pharmaceutical Latest Developments

13.9 Yabao Pharmaceutical Group

13.9.1 Yabao Pharmaceutical Group Company Information

13.9.2 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Offered

13.9.3 Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Yabao Pharmaceutical Group Main Business Overview

13.9.5 Yabao Pharmaceutical Group Latest Developments

13.10 Sihuan Pharmaceutical

13.10.1 Sihuan Pharmaceutical Company Information

13.10.2 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

13.10.3 Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Sihuan Pharmaceutical Main Business Overview

13.10.5 Sihuan Pharmaceutical Latest Developments

13.11 Jiangsu Kanion Pharmaceutical

13.11.1 Jiangsu Kanion Pharmaceutical Company Information

13.11.2 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

13.11.3 Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Jiangsu Kanion Pharmaceutical Main Business Overview

13.11.5 Jiangsu Kanion Pharmaceutical Latest Developments

13.12 Shandong Yunmen Pharmaceutical

13.12.1 Shandong Yunmen Pharmaceutical Company Information

13.12.2 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

13.12.3 Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Shandong Yunmen Pharmaceutical Main Business Overview

13.12.5 Shandong Yunmen Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Nimodipine Sustained Release Tablets Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Nimodipine Sustained Release Tablets Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 30mg/Piece

Table 4. Major Players of 60mg/Piece

Table 5. Major Players of Others

Table 6. Global Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)

Table 7. Global Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)

Table 8. Global Nimodipine Sustained Release Tablets Revenue by Type (2017-2022) & ($ million)

Table 9. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2017-2022)

Table 10. Global Nimodipine Sustained Release Tablets Sale Price by Type (2017-2022) & (US$/Unit)

Table 11. Global Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)

Table 12. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)

Table 13. Global Nimodipine Sustained Release Tablets Revenue by Application (2017-2022)

Table 14. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application (2017-2022)

Table 15. Global Nimodipine Sustained Release Tablets Sale Price by Application (2017-2022) & (US$/Unit)

Table 16. Global Nimodipine Sustained Release Tablets Sales by Company (2020-2022) & (K Units)

Table 17. Global Nimodipine Sustained Release Tablets Sales Market Share by Company (2020-2022)

Table 18. Global Nimodipine Sustained Release Tablets Revenue by Company (2020-2022) ($ Millions)

Table 19. Global Nimodipine Sustained Release Tablets Revenue Market Share by Company (2020-2022)

Table 20. Global Nimodipine Sustained Release Tablets Sale Price by Company (2020-2022) & (US$/Unit)

Table 21. Key Manufacturers Nimodipine Sustained Release Tablets Producing Area Distribution and Sales Area

Table 22. Players Nimodipine Sustained Release Tablets Products Offered

Table 23. Nimodipine Sustained Release Tablets Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 24. New Products and Potential Entrants

Table 25. Mergers & Acquisitions, Expansion

Table 26. Global Nimodipine Sustained Release Tablets Sales by Geographic Region (2017-2022) & (K Units)

Table 27. Global Nimodipine Sustained Release Tablets Sales Market Share Geographic Region (2017-2022)

Table 28. Global Nimodipine Sustained Release Tablets Revenue by Geographic Region (2017-2022) & ($ millions)

Table 29. Global Nimodipine Sustained Release Tablets Revenue Market Share by Geographic Region (2017-2022)

Table 30. Global Nimodipine Sustained Release Tablets Sales by Country/Region (2017-2022) & (K Units)

Table 31. Global Nimodipine Sustained Release Tablets Sales Market Share by Country/Region (2017-2022)

Table 32. Global Nimodipine Sustained Release Tablets Revenue by Country/Region (2017-2022) & ($ millions)

Table 33. Global Nimodipine Sustained Release Tablets Revenue Market Share by Country/Region (2017-2022)

Table 34. Americas Nimodipine Sustained Release Tablets Sales by Country (2017-2022) & (K Units)

Table 35. Americas Nimodipine Sustained Release Tablets Sales Market Share by Country (2017-2022)

Table 36. Americas Nimodipine Sustained Release Tablets Revenue by Country (2017-2022) & ($ Millions)

Table 37. Americas Nimodipine Sustained Release Tablets Revenue Market Share by Country (2017-2022)

Table 38. Americas Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)

Table 39. Americas Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)

Table 40. Americas Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)

Table 41. Americas Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)

Table 42. APAC Nimodipine Sustained Release Tablets Sales by Region (2017-2022) & (K Units)

Table 43. APAC Nimodipine Sustained Release Tablets Sales Market Share by Region (2017-2022)

Table 44. APAC Nimodipine Sustained Release Tablets Revenue by Region (2017-2022) & ($ Millions)

Table 45. APAC Nimodipine Sustained Release Tablets Revenue Market Share by Region (2017-2022)

Table 46. APAC Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)

Table 47. APAC Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)

Table 48. APAC Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)

Table 49. APAC Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)

Table 50. Europe Nimodipine Sustained Release Tablets Sales by Country (2017-2022) & (K Units)

Table 51. Europe Nimodipine Sustained Release Tablets Sales Market Share by Country (2017-2022)

Table 52. Europe Nimodipine Sustained Release Tablets Revenue by Country (2017-2022) & ($ Millions)

Table 53. Europe Nimodipine Sustained Release Tablets Revenue Market Share by Country (2017-2022)

Table 54. Europe Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)

Table 55. Europe Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)

Table 56. Europe Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)

Table 57. Europe Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)

Table 58. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Country (2017-2022) & (K Units)

Table 59. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Country (2017-2022)

Table 60. Middle East & Africa Nimodipine Sustained Release Tablets Revenue by Country (2017-2022) & ($ Millions)

Table 61. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Market Share by Country (2017-2022)

Table 62. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Type (2017-2022) & (K Units)

Table 63. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Type (2017-2022)

Table 64. Middle East & Africa Nimodipine Sustained Release Tablets Sales by Application (2017-2022) & (K Units)

Table 65. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)

Table 66. Key Market Drivers & Growth Opportunities of Nimodipine Sustained Release Tablets

Table 67. Key Market Challenges & Risks of Nimodipine Sustained Release Tablets

Table 68. Key Industry Trends of Nimodipine Sustained Release Tablets

Table 69. Nimodipine Sustained Release Tablets Raw Material

Table 70. Key Suppliers of Raw Materials

Table 71. Nimodipine Sustained Release Tablets Distributors List

Table 72. Nimodipine Sustained Release Tablets Customer List

Table 73. Global Nimodipine Sustained Release Tablets Sales Forecast by Region (2023-2028) & (K Units)

Table 74. Global Nimodipine Sustained Release Tablets Sales Market Forecast by Region

Table 75. Global Nimodipine Sustained Release Tablets Revenue Forecast by Region (2023-2028) & ($ millions)

Table 76. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Region (2023-2028)

Table 77. Americas Nimodipine Sustained Release Tablets Sales Forecast by Country (2023-2028) & (K Units)

Table 78. Americas Nimodipine Sustained Release Tablets Revenue Forecast by Country (2023-2028) & ($ millions)

Table 79. APAC Nimodipine Sustained Release Tablets Sales Forecast by Region (2023-2028) & (K Units)

Table 80. APAC Nimodipine Sustained Release Tablets Revenue Forecast by Region (2023-2028) & ($ millions)

Table 81. Europe Nimodipine Sustained Release Tablets Sales Forecast by Country (2023-2028) & (K Units)

Table 82. Europe Nimodipine Sustained Release Tablets Revenue Forecast by Country (2023-2028) & ($ millions)

Table 83. Middle East & Africa Nimodipine Sustained Release Tablets Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Global Nimodipine Sustained Release Tablets Sales Forecast by Type (2023-2028) & (K Units)

Table 86. Global Nimodipine Sustained Release Tablets Sales Market Share Forecast by Type (2023-2028)

Table 87. Global Nimodipine Sustained Release Tablets Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 88. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Type (2023-2028)

Table 89. Global Nimodipine Sustained Release Tablets Sales Forecast by Application (2023-2028) & (K Units)

Table 90. Global Nimodipine Sustained Release Tablets Sales Market Share Forecast by Application (2023-2028)

Table 91. Global Nimodipine Sustained Release Tablets Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 92. Global Nimodipine Sustained Release Tablets Revenue Market Share Forecast by Application (2023-2028)

Table 93. Bionpharma Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 94. Bionpharma Nimodipine Sustained Release Tablets Product Offered

Table 95. Bionpharma Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 96. Bionpharma Main Business

Table 97. Bionpharma Latest Developments

Table 98. Arbor Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 99. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

Table 100. Arbor Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 101. Arbor Pharmaceuticals Main Business

Table 102. Arbor Pharmaceuticals Latest Developments

Table 103. Sofgen Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 104. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

Table 105. Sofgen Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 106. Sofgen Pharmaceuticals Main Business

Table 107. Sofgen Pharmaceuticals Latest Developments

Table 108. Pharmaceutics International Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 109. Pharmaceutics International Nimodipine Sustained Release Tablets Product Offered

Table 110. Pharmaceutics International Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 111. Pharmaceutics International Main Business

Table 112. Pharmaceutics International Latest Developments

Table 113. Heritage Pharmaceuticals Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 114. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Product Offered

Table 115. Heritage Pharmaceuticals Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 116. Heritage Pharmaceuticals Main Business

Table 117. Heritage Pharmaceuticals Latest Developments

Table 118. Bayer Vital Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 119. Bayer Vital Nimodipine Sustained Release Tablets Product Offered

Table 120. Bayer Vital Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 121. Bayer Vital Main Business

Table 122. Bayer Vital Latest Developments

Table 123. Wuhan HITECK Biopharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 124. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 125. Wuhan HITECK Biopharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 126. Wuhan HITECK Biopharmaceutical Main Business

Table 127. Wuhan HITECK Biopharmaceutical Latest Developments

Table 128. Qilu Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 129. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 130. Qilu Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 131. Qilu Pharmaceutical Main Business

Table 132. Qilu Pharmaceutical Latest Developments

Table 133. Yabao Pharmaceutical Group Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 134. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Product Offered

Table 135. Yabao Pharmaceutical Group Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 136. Yabao Pharmaceutical Group Main Business

Table 137. Yabao Pharmaceutical Group Latest Developments

Table 138. Sihuan Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 139. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 140. Sihuan Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 141. Sihuan Pharmaceutical Main Business

Table 142. Sihuan Pharmaceutical Latest Developments

Table 143. Jiangsu Kanion Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 144. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 145. Jiangsu Kanion Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 146. Jiangsu Kanion Pharmaceutical Main Business

Table 147. Jiangsu Kanion Pharmaceutical Latest Developments

Table 148. Shandong Yunmen Pharmaceutical Basic Information, Nimodipine Sustained Release Tablets Manufacturing Base, Sales Area and Its Competitors

Table 149. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Product Offered

Table 150. Shandong Yunmen Pharmaceutical Nimodipine Sustained Release Tablets Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 151. Shandong Yunmen Pharmaceutical Main Business

Table 152. Shandong Yunmen Pharmaceutical Latest Developments

List of Figures

Figure 1. Picture of Nimodipine Sustained Release Tablets

Figure 2. Nimodipine Sustained Release Tablets Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nimodipine Sustained Release Tablets Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Nimodipine Sustained Release Tablets Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Nimodipine Sustained Release Tablets Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 30mg/Piece

Figure 10. Product Picture of 60mg/Piece

Figure 11. Product Picture of Others

Figure 12. Global Nimodipine Sustained Release Tablets Sales Market Share by Type in 2021

Figure 13. Global Nimodipine Sustained Release Tablets Revenue Market Share by Type (2017-2022)

Figure 14. Nimodipine Sustained Release Tablets Consumed in Hospital

Figure 15. Global Nimodipine Sustained Release Tablets Market: Hospital (2017-2022) & (K Units)

Figure 16. Nimodipine Sustained Release Tablets Consumed in Pharmacy

Figure 17. Global Nimodipine Sustained Release Tablets Market: Pharmacy (2017-2022) & (K Units)

Figure 18. Nimodipine Sustained Release Tablets Consumed in Others

Figure 19. Global Nimodipine Sustained Release Tablets Market: Others (2017-2022) & (K Units)

Figure 20. Global Nimodipine Sustained Release Tablets Sales Market Share by Application (2017-2022)

Figure 21. Global Nimodipine Sustained Release Tablets Revenue Market Share by Application in 2021

Figure 22. Nimodipine Sustained Release Tablets Revenue Market by Company in 2021 ($ Million)

Figure 23. Global Nimodipine Sustained Release Tablets Revenue Market Share by Company in 2021

Figure 24. Global Nimodipine Sustained Release Tablets Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global Nimodipine Sustained Release Tablets Revenue Market Share by Geographic Region in 2021

Figure 26. Global Nimodipine Sustained Release Tablets Sales Market Share by Region (2017-2022)

Figure 27. Global Nimodipine Sustained Release Tablets Revenue Market Share by Country/Region in 2021

Figure 28. Americas Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)

Figure 29. Americas Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)

Figure 30. APAC Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)

Figure 31. APAC Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)

Figure 32. Europe Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)

Figure 33. Europe Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa Nimodipine Sustained Release Tablets Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa Nimodipine Sustained Release Tablets Revenue 2017-2022 ($ Millions)

Figure 36. Americas Nimodipine Sustained Release Tablets Sales Market Share by Country in 2021

Figure 37. Americas Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2021

Figure 38. United States Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC Nimodipine Sustained Release Tablets Sales Market Share by Region in 2021

Figure 43. APAC Nimodipine Sustained Release Tablets Revenue Market Share by Regions in 2021

Figure 44. China Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 48. India Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe Nimodipine Sustained Release Tablets Sales Market Share by Country in 2021

Figure 51. Europe Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2021

Figure 52. Germany Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 53. France Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa Nimodipine Sustained Release Tablets Sales Market Share by Country in 2021

Figure 58. Middle East & Africa Nimodipine Sustained Release Tablets Revenue Market Share by Country in 2021

Figure 59. Egypt Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country Nimodipine Sustained Release Tablets Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of Nimodipine Sustained Release Tablets in 2021

Figure 65. Manufacturing Process Analysis of Nimodipine Sustained Release Tablets

Figure 66. Industry Chain Structure of Nimodipine Sustained Release Tablets

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles